Lipoprotein (a) and apolipoprotein (a) isoforms in patients with coronary artery disease documented by angiographydoi:10.1016/S0021-9150(99)80056-2C.S.KatsourasandS.A.KarabinaandJ.A.GoudevenosandM.SDOSAtherosclerosis
Lipoprotein(a) in PROCAM Participants and Young Myocardial Infarction Survivors Genetically determined structural variation in apolipoproteins E, B and (a) contributes to primary dyslipoproteinaemia and atherosclerotic risk in the population. Recent advances in molecular biological techniques have much facilit...
However, it is well known that there is an inverse correlation between Lp(a) concentration and apolipoprotein (a) (apo(a)) isoform size. Thus, it is imperative to exclude differences in apo(a) isoform frequencies between subjects with or without thyroid autoimmunity in order to verify if ...
The relationship between lipoprotein(a) [Lp(a)] and restenosis after intracoronary stent implantation has never been analysed in diabetic patients. The aim of the present prospective study was to evaluate whether Lp(a) levels and apolipoprotein(a) [apo(a)] phenotypes are predictors of restenosis ...
Lipoprotein (a), formed by the attachment of low-density lipoprotein to apolipoprotein(a) [apo(a)] by a single disulfide bond, is a circulating particle of uncertain physiologic function that exhibits atherogenic and pro-thrombotic/anti-fibrinolytic properties in experimental settings [3]. Plasma le...
Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents †Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents †ascendencia, parent, trouble circulatoire, ascendance, trastornos circulator...
Interrelation between apolipoprotein A-I and lipoprotein(a) in patients with coronary heart disease. XIVth Congress of the International Society on Thrombosis and Haemostasis 来自 ResearchGate 喜欢 0 阅读量: 12 作者: M Pergolini 摘要: The results and validity of some of the latest and most ...
This study sought to examine the relationship between baseline and on-study apolipoproteins (apo) A-1 and B and lipoprotein(a) [Lp(a)] levels and the development of subsequent cardiovascular (CV) events in the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Trigl...
Background: Retention of apolipoprotein B (apoB)-containing lipoproteins within the arterial wall plays a major causal role in atherosclerotic cardiovascular disease (ASCVD). There is a single apoB molecule in all apoB-containing lipoproteins. Therefore, quantitation of apoB directly estimates the num...
To test whether apolipoprotein [a] (apo[a]) mediates the clearance of Lp[a] from plasma, we coinjected excess apo[a] with labeled Lp[a]. Apo[a] acted as a potent inhibitor of Lp[a] plasma clearance. Asialofetuin, a ligand of the asialoglycoprotein receptor, did not inhibit Lp[a...